1 Berufsgenossenschaftliches Universitätsklinikum Bochum Bergmannsheil, Department of Neurology, Bochum, Germany.
2 Marienhospital Bottrop, Department of Anesthesiology, Bottrop, Germany.
Cephalalgia. 2017 Sep;37(10):998-1000. doi: 10.1177/0333102416653387. Epub 2016 Jun 2.
Background Hypnic headache is a rare primary headache disorder with a few hundred described cases so far. Due to the fact that this headache disease is rare, there are no placebo-controlled oral medication studies. After all reported oral medication failed to control pain symptoms of a hypnic headache disease, we were able to reduce pain intensity and frequency via two greater occipital nerve (GON) blocks. Case We report on a 74-year-old patient diagnosed with hypnic headache in our headache outpatient department two years ago. Over a course of nine months none of the recommended oral drugs had an effect in pain alleviation and we decided to try an occipital nerve injection therapy. Two GON-blocks then led to a stable and significant pain reduction over the course of six months during monthly follow-ups. Conclusion GON block can be a successful therapeutic approach for the treatment of hypnic headache when oral medication fails.
背景 催眠性头痛是一种罕见的原发性头痛疾病,迄今为止已有数百例描述。由于这种头痛疾病较为罕见,因此没有安慰剂对照的口服药物研究。在所有报告的口服药物均未能控制催眠性头痛疾病的疼痛症状后,我们通过两次枕大神经(GON)阻滞成功减轻了疼痛强度和频率。 案例 我们报告了一位 74 岁的患者,他两年前在我们的头痛门诊被诊断出患有催眠性头痛。在九个月的时间里,没有一种推荐的口服药物对缓解疼痛有效,我们决定尝试枕大神经注射治疗。两次 GON 阻滞导致在六个月的每月随访期间疼痛显著减轻且稳定。 结论 当口服药物治疗失败时,GON 阻滞可能是治疗催眠性头痛的一种成功治疗方法。